Fonte: Brazilian Journal of Medical and Biological Research. Unidade: FM
Assuntos: QUIMIOTERAPIA ADJUVANTE, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO, NEOPLASIAS MAMÁRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PETRY, V. et al. Metronomic chemotherapy in the neoadjuvant setting: results of two parallel feasibility trials (TraQme and TAME) in patients with HER2+ and HER2− locally advanced breast cancer. Brazilian Journal of Medical and Biological Research, v. 48, n. 5, p. 479-485, 2015Tradução . . Disponível em: https://doi.org/10.1590/1414-431x20144354. Acesso em: 23 abr. 2024.APA
Petry, V., Gagliato, D. M., Leal, A. I. C., Arai, R. J., Longo, E., Andrade, F., et al. (2015). Metronomic chemotherapy in the neoadjuvant setting: results of two parallel feasibility trials (TraQme and TAME) in patients with HER2+ and HER2− locally advanced breast cancer. Brazilian Journal of Medical and Biological Research, 48( 5), 479-485. doi:10.1590/1414-431x20144354NLM
Petry V, Gagliato DM, Leal AIC, Arai RJ, Longo E, Andrade F, Ricci MD, Piato JR, Barroso-Sousa R, Hoff PM, Mano MS. Metronomic chemotherapy in the neoadjuvant setting: results of two parallel feasibility trials (TraQme and TAME) in patients with HER2+ and HER2− locally advanced breast cancer [Internet]. Brazilian Journal of Medical and Biological Research. 2015 ; 48( 5): 479-485.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1590/1414-431x20144354Vancouver
Petry V, Gagliato DM, Leal AIC, Arai RJ, Longo E, Andrade F, Ricci MD, Piato JR, Barroso-Sousa R, Hoff PM, Mano MS. Metronomic chemotherapy in the neoadjuvant setting: results of two parallel feasibility trials (TraQme and TAME) in patients with HER2+ and HER2− locally advanced breast cancer [Internet]. Brazilian Journal of Medical and Biological Research. 2015 ; 48( 5): 479-485.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1590/1414-431x20144354
